Related Experiment Video
Updated: Jul 17, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
[Early and long-term results of valve replacement in patients on chronic hemodialysis]
Sumio Miura1, I Kigawa, T Kitamura
1Department of Cardiovascular Surgery, Mitsui Memorial Hospital, Tokyo, Japan.
Insights
Cardiac valve replacement is high-risk for hemodialysis patients. This study found high operative mortality and low long-term survival rates, with significant bleeding and stroke complications.
Area of Science:
- Cardiology
- Nephrology
- Cardiac Surgery
Context:
- Cardiac valve replacement is a high-risk procedure for patients undergoing hemodialysis.
- Outcomes of this patient population are often questioned due to increased perioperative and long-term complications.
Purpose:
- To evaluate the early and long-term outcomes of cardiac valve replacement in hemodialysis patients at a single institution.
Summary:
- This retrospective study analyzed 41 hemodialysis patients who underwent valve replacement between 1978 and 2004.
- Bioprosthetic valves were used in 12.2% of cases.
- The 30-day operative mortality was 17%, with an in-hospital death rate of 22%.
- Long-term survival rates at 2, 3, 5, and 10 years were 68%, 54%, 49%, and 27%, respectively.
- Major bleeding and stroke occurred in 41% of patients.
Impact:
- The findings highlight the significant risks associated with cardiac valve replacement in hemodialysis patients.
- Results indicate a need for careful patient selection and management strategies to improve outcomes.
- This data provides valuable insights for clinicians managing this complex patient cohort.
Abstract:
Cardiac valve replacement carries a high-risk in hemodialysis patients and has been questioned for its results. The purpose of this study is to focus on the early and long-term results in our institution. We retrospectively analyzed the data from 41 hemodialysis patients who underwent valve replacement in our unit from July 1978 to March 2004. Bioprosthetic valves were used in 5 patients (12.2%). The overall operative mortality (30 days) was 17%. The in-hospital death rate was 22%. Late survival rate was 68% at 2 years, 54% at 3 years, 49% at 5 years, and 27% at 10 years for all patients. The incidence of major bleeding and stroke was 41%.
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Continuous Renal Replacement Therapy
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management

